Clinical Trial

US grants Pfizer Covid vaccine full approval, move makes children under 12 eligible if needed

The US military has previously announced it will mandate the vaccine as soon as it receives full approval, and a slew of private businesses and universities are expected to follow

Demystifying clinical trials: Everything you need to know about process, safety, eligibility

Increased public awareness and proactive participation in clinical trials are the keys to developing new treatments for of diseases in India and around the globe.

Bharat Biotech set for Phase 4 trials but Phase 3 data still not out; all you need to know

A peer review of the jab is expected in two to four months after it was given to scientific journals, Raches Ella Project Lead COVID-19 Vaccines at Bharat Biotech said on Wednesday

Covaxin trials on children underway at AIIMS Delhi and Patna: All you need to know

India has no COVID-19 vaccine for children yet. If the phase 2/3 trials on children are successful, COVAXIN will be used to inoculate India's children

Bharat Biotech to pay compensation if Covaxin causes 'severe adverse reaction' in recipients

The central licensing authority has granted permission for the sale or distribution of Covaxin for restricted use in emergency situations in public interest as an abundant caution, in clinical trial mode

Chinese officials have said that COVID-19 vaccine will be ready for the public by November

There are currently nine vaccine candidates in late-stage human trials, although pharma giant AstraZeneca paused their trials after a volunteer developed an unexplained illness.

Holy Grail: Vaccine made from mosquito spit could protect people from all kinds of vector borne diseases

The initial results from the trial showed that an Anopheles mosquito-based vaccine was safe and it triggered antibody and cellular responses.

Glenmark to study potential COVID-19 drug combination; to look to enroll 158 hospitalised patients

On 1 May, Glenmark Pharmaceuticals said it has become the first company in India to receive approval from Drug Controller General of India (DCGI) to conduct clinical trials of Favipiravir antiviral tablets for the treatment of COVID-19 patients.

iGate Enables Token Based Remote Database Access

William Dias, system analyst, iGate Clinical Research International, talks about how the company is leveraging IT for its various operations.

Drug makers choose margins over 'India advantage', invest in overseas R&D

India's $15 billion a year pharma industry, the world's largest source of cheap generics, is already reeling from a string of drug recalls and quality control issues which have called into question the regulator's oversight.<br />